期刊文献+

271例2型糖尿病患者血清C反应蛋白水平、白细胞计数与踝肱指数关系分析 被引量:1

Relation of C-reactive protein and white blood cell count with the ankle-brachial index in type 2 diabetes
下载PDF
导出
摘要 测定271例2型糖尿患者血清C反应蛋白(C-RP)水平、白细胞(WBC)计数与踝肱指数(ABI),ABI<0.9组患者血清C-RP水平、WBC计数与ABI>0.9组的差异有统计学意义(P<0.01)。由此推断,血清C-RP水平与ABI有相关性;WBC计数与ABI的关系值得进一步探讨。 To investigate the relations of the C-reactive protein (C-RP) concentration and white blood cell count with the ankle-brachial index (ABI) in type 2 diabetes mellitus(T2DM). C-RP concentrations, ABI and other metabolism parameters were determined in lower ABI patients as well as normal ABI controls. Serum C- RP levels and the WBC count showed a statistically significant difference between lower and normal ABI groups. The level of serum CRP was related to the ABI.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2007年第10期606-608,共3页 Chinese Journal of Diabetes
关键词 C反应蛋白 白细胞 踝肱指数 C-reactive protein White blood cell Ankle-brachial index
  • 相关文献

参考文献5

  • 1Cui R,Iso H,Yamagishi K,et al.Ankle-arm blood pressure index and cardiovascular risk factors In elderly Japanese men.Hypertens Res,2003,26:377-382.
  • 2Yu HI,Sheu WH,Song YM,et al.C-reactive protein and risk factors for peripheral vascular disease in subjects with type 2 diabetes mellitus.Diabet Med,2004,21:336 -341.
  • 3McDermott MM,Green D,Greenland P,et al.Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index.Am J Cardiol,2003,92:194-199.
  • 4Tong C,Lee KF,So WY,et al.White blood cell count is associated with macro-and microvascular complications in Chinese patients with Type 2 diabetes.Diabetes Care,2004,27:216-222.
  • 5Nissen SE,Tuzcu EM,Schoenhagen P,et al.Statin therapy,LDL cholesterol,C-reactive protein,and coronary artery disease.N Engl J Med,2005,352:29-38.

同被引文献9

  • 1Yasuda M, Kiyohara Y, Wang J J, et al. High serum bilirubin levels and diabetic retinopathy : the Hisayama Study [J]. Oph- thalmology, 2011, 118(7) :1423 -8.
  • 2UK Prospective Diabetes Study Group. Tight blood pressure control and risk of maerovascular and microvaseular complications in type 2 diabetes: UKPDS38 [J]. BMJ, 1998, 317(7160):703-13.
  • 3Parving H H, Lehnert H, Briehner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in pa- tients with type 2 diabetes [J]. N Engl J Med, 2001, 345 (12) :870 - 8.
  • 4Morton J, Zoungas S, Li Q, et al. Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the AD- VANCE study [ J]. Diabetes Care, 2012, 35 (11 ):2201 -6.
  • 5Hwang H J, Lee S W, Kim S H. Relationship between bilirubin and C-reactive protein [J]. Clin Chem Lab Med, 2011,49 ( 11 ) : 1823 -8.
  • 6Kundur A R, Singh I, Bulmer A C. Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert;s syndrome? [ J]. Atherosclerosis, 2015, 239 ( 1 ) :73 - 84.
  • 7高璐,于德民.2型糖尿病患者外周血白细胞计数与尿白蛋白相关性的研究[J].中国糖尿病杂志,2008,16(1):12-14. 被引量:6
  • 8沈文清,邢艳芳,钱捷,梁敏灵,黄丽.糖尿病肾病患者血清脂蛋白C反应蛋白载脂蛋白检测及其临床意义[J].中华老年医学杂志,2012,31(6):495-497. 被引量:22
  • 9赵然,常宝成,单春艳,杨菊红,徐延光,王颖,任惠珠,郑妙艳,王晓宇,王珊珊,陈莉明.2型糖尿病患者预估肾小球滤过率与血清胆红素的相关性[J].中华糖尿病杂志,2014,6(4):241-244. 被引量:13

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部